SCHEMBL28884665

SCHEMBL28884665

N[C@@](Cc1ccc(OCc2ccccc2)cc1)(C(=O)O)C(=O)OCC1c2ccccc2-c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ PARP10 Q53GL7 1/20 0.42
▸ FFAR1 O14842 1/20 0.41
▸ FFAR4 Q5NUL3 1/20 0.41
▸ S1PR5 Q9H228 1/20 0.41
▸ NR4A1 P22736 1/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ NR4A3 Q92570 1/20 0.41
▸ MAOB P27338 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ LTA4H P09960 3/20 0.41
▸ LAP3 P28838 1/20 0.41
▸ PLA2G4B P0C869 1/20 0.40
▸ PPARG P37231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28884667 1.00 SMN1; SMN2 (0.45) SMN1; SMN2HIF1AKMT2APARP10FFAR1
SCHEMBL29019464 0.90 SMN1; SMN2 (0.55) SMN1; SMN2HIF1AKMT2AMAPTFABP7
SCHEMBL27522574 0.90 SMN1; SMN2 (0.55) SMN1; SMN2HIF1AKMT2AMAPTFABP7
SCHEMBL5264305 0.90 SMN1; SMN2 (0.55) SMN1; SMN2HIF1AKMT2AMAPTFABP7
SCHEMBL1311053 0.87 FABP5 (0.44) SMN1; SMN2HIF1AKMT2AGAAFABP7
SCHEMBL29019435 0.85 SMN1; SMN2 (0.42) SMN1; SMN2HIF1AKMT2APPARGFABP7
SCHEMBL28356620 0.85 SMN1; SMN2 (0.42) SMN1; SMN2HIF1AKMT2APPARGFABP7
SCHEMBL29019459 0.85 SMN1; SMN2 (0.42) SMN1; SMN2HIF1AKMT2APPARGFABP7
SCHEMBL31522725 0.85 LTA4H (0.44) SMN1; SMN2HIF1AKMT2AMAPTRAB9A
SCHEMBL16634841 0.84 SMN1; SMN2 (0.46) SMN1; SMN2HIF1AKMT2APPARGFABP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117615792-A Conjugates of checkpoint inhibitors with IL-2 and uses thereof 明峰治疗股份公司 2024-02-27 — — CN disclosed
CN-117615794-A Checkpoint inhibitors conjugated to IL-2 and uses thereof 明峰治疗股份公司 2024-02-27 — — CN disclosed
CN-117615793-A Antibody conjugates and their preparation 明峰治疗股份公司 2024-02-27 — — CN disclosed
CN-117616036-A Modified IL-2 polypeptides for the treatment of inflammatory and autoimmune diseases 明峰治疗股份公司 2024-02-27 — — CN disclosed
CN-115315436-A Modified IL-2 polypeptides and uses thereof 明峰治疗股份公司 2022-11-08 — — CN disclosed
Send feedback